Radiation therapy for non-rhabdomyosarcoma soft tissue sarcomas in adolescents and young adults.
Non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) are less responsive to radiotherapy than the more common pediatric soft tissue sarcomas, rhabdomyosarcoma and Ewing sarcoma of soft tissue. However, radiation therapy does play an important role in the treatment of NRSTS, including synovial sarcoma. Little data exists regarding the behavior or treatment of these tumors in adolescents and young adults compared to older populations. Limb-preservation with adjuvant radiation thereby is standard. There is a greater incentive to reduce long-term complications of radiation in younger patients and thus smaller margins, lower doses, and conformal techniques should be considered. Results of anticipated cooperative group studies promise to guide future therapy for the various types of NRSTS.
Wolden
Suzanne L
SL
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. woldens@mskcc.org
D000293:Adolescent; D000328:Adult; D001918:Brachytherapy; D006801:Humans; D017410:Practice Guidelines as Topic; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D012208:Rhabdomyosarcoma / Q000473:pathology / Q000532:radiotherapy*; D012509:Sarcoma / Q000473:pathology / Q000532:radiotherapy*